Development and assessment of antiatherosclerotic therapies beyond low-density lipoprotein cholesterol and blood pressure.
Ballantyne
C M
CM
Section of Atherosclerosis, Department of Medicine, Baylor College of Medicine, 6565 Fannin, M.S. A-601, Houston, TX 77030, USA. cmb@bcm.tmc.edu
D015906:Angioplasty, Balloon, Coronary; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D015415:Biomarkers; D001781:Blood Component Removal; D023521:Chlamydophila Infections / Q000150:complications / Q000188:drug therapy; D016993:Chlamydophila pneumoniae / Q000472:pathogenicity; D008078:Cholesterol, LDL / Q000097:blood; D003327:Coronary Disease / Q000209:etiology / Q000517:prevention & control / Q000628:therapy*; D015914:Estrogen Replacement Therapy; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D006973:Hypertension / Q000628:therapy; D008297:Male; D009765:Obesity / Q000628:therapy; D012307:Risk Factors
D000924:Anticholesteremic Agents; D015415:Biomarkers; D008078:Cholesterol, LDL